LYOMAC Shines at Asia Pharma Expo 2026 in Bangladesh, Empowering South Asian Pharmaceutical Upgrade

(Dhaka, Bangladesh, March 31, 2026) Recently, the 17th Asia Pharma Expo 2026 successfully concluded at the Bangladesh-China Friendship Exhibition Center (BCFEC) in Dhaka, the capital of Bangladesh. Zhejiang Lyomac Pharmaceutical Equipment Co., Ltd. (LYOMAC) exhibited its full range of high-end freeze drying equipment and customized solutions, including LYOPRO production-scale, LYOPILOT pilot-scale, and LYOLAB lab-scale freeze dryers. With FDA/GMP compliant design, precise temperature control technology and efficient sterile integration solutions, LYOMAC became a highlight of the exhibition and deeply connected with the needs of the South Asian pharmaceutical market.

As the largest and most influential pharmaceutical industry event in Bangladesh and South Asia, this year's Asia Pharma Expo gathered more than 800 exhibitors from 32 countries and over 14,500 professional visitors, with an exhibition area of 23,500 square meters. The exhibition focuses on the entire pharmaceutical industry chain technology and equipment, building a core platform for technical exchange, business cooperation and market expansion for global pharmaceutical companies. Currently, Bangladesh's pharmaceutical industry can meet 98% of domestic drug demand, export to 157 countries and regions, and the market size is expected to exceed 6 billion US dollars in 2026, with an increasingly urgent demand for high-end compliant freeze drying equipment.

LYOMAC's booth was presented in a minimalist business style, with three core freeze drying series on display, fully demonstrating the company's technical strength and compliance capabilities in the high-end pharmaceutical field:

• LYOPRO Production-Scale Freeze Dryer: Designed for large-scale commercial production, equipped with 316L stainless steel high-cleanliness shelves (Ra≤0.6μm), precise temperature control system (±0.5℃) and high-efficiency vacuum unit. It can be seamlessly integrated with CIP/SIP in-place cleaning and sterilization, SUB door aseptic transfer and other modules to meet the large-scale production needs of biopharmaceuticals, vaccines and high-potency drugs.

• LYOPILOT Pilot-Scale Freeze Dryer: Adopts the same platform design as the production model, supporting process scale-up and formula verification, providing efficient and convertible solutions for pharmaceutical companies in the pilot stage, accelerating the R&D of innovative drugs and generic drugs.

• LYOLAB Lab-Scale Freeze Dryer: Suitable for laboratory small-scale trials and formula screening, compact in size and flexible in operation, while retaining core compliance design to provide reliable support for early R&D.

During the exhibition, LYOMAC focused on showcasing sterile integration solutions and automation configuration capabilities, including automatic loading/unloading systems, Isolator/RABS interfaces, 21 CFR Part 11 data traceability modules, etc., accurately matching the needs of Bangladeshi pharmaceutical companies for high-end and international transformation. The on-site reception exceeded 200 groups of professional visitors, covering major local pharmaceutical companies in Bangladesh, regional distributors in South Asia and industry technical experts. The one-on-one negotiations were enthusiastic, and many customers expressed in-depth cooperation intentions.

Robert Wang, Chairman of LYOMAC, said: "Bangladesh and South Asia are core regions for the rapid growth of the global pharmaceutical industry, and pharmaceutical companies' demand for compliant, efficient and customizable pharmaceutical equipment continues to escalate. This exhibition is not only a concentrated display of LYOMAC's technical strength, but also a key step for us to deepen the South Asian market and improve our global layout. We will rely on FDA/GMP compliant design and localized service capabilities to provide local pharmaceutical companies with adapted high-end freeze drying solutions, helping them improve product quality and expand international markets."

This exhibition further strengthened LYOMAC's brand influence in the South Asian region, laying a solid foundation for subsequent business expansion and partner recruitment. In the future, LYOMAC will continue to focus on process scale-up and compliance innovation, take high-end pharmaceutical equipment as the core, and promote in-depth penetration and win-win cooperation in the global market.

About LYOMAC

Zhejiang Lyomac Pharmaceutical Equipment Co., Ltd. (LYOMAC) is a national high-tech enterprise focusing on the R&D, production and sales of high-end pharmaceutical freeze drying equipment, with more than 20 years of R&D experience in pharmaceutical equipment and professional management background. The company's products cover the whole scene of R&D, pilot and production, strictly follow international standards such as FDA, cGMP and EMA, provide full-process services from equipment selection, customized configuration to verification support, and are exported to many countries around the world such as Europe, America and Southeast Asia, committed to becoming a core partner in the global high-end pharmaceutical equipment field.